DE69128238T2 - Nachweis von thrombopenies - Google Patents

Nachweis von thrombopenies

Info

Publication number
DE69128238T2
DE69128238T2 DE69128238T DE69128238T DE69128238T2 DE 69128238 T2 DE69128238 T2 DE 69128238T2 DE 69128238 T DE69128238 T DE 69128238T DE 69128238 T DE69128238 T DE 69128238T DE 69128238 T2 DE69128238 T2 DE 69128238T2
Authority
DE
Germany
Prior art keywords
inducer drug
thrombocytopeniae
inducer
drug
antigenic substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69128238T
Other languages
English (en)
Other versions
DE69128238D1 (de
Inventor
Jean Amiral
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostica Stago SAS
Original Assignee
Diagnostica Stago SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostica Stago SAS filed Critical Diagnostica Stago SAS
Publication of DE69128238D1 publication Critical patent/DE69128238D1/de
Application granted granted Critical
Publication of DE69128238T2 publication Critical patent/DE69128238T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Record Carriers (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69128238T 1990-08-09 1991-08-09 Nachweis von thrombopenies Expired - Lifetime DE69128238T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9010190A FR2665769B1 (fr) 1990-08-09 1990-08-09 Determination des thrombopenies notamment induites par l'heparine au moyen du facteur plaquettaire 4.
PCT/FR1991/000659 WO1992002823A1 (fr) 1990-08-09 1991-08-09 Determination des thrombopenies

Publications (2)

Publication Number Publication Date
DE69128238D1 DE69128238D1 (de) 1998-01-02
DE69128238T2 true DE69128238T2 (de) 1998-06-25

Family

ID=9399577

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128238T Expired - Lifetime DE69128238T2 (de) 1990-08-09 1991-08-09 Nachweis von thrombopenies

Country Status (7)

Country Link
EP (1) EP0495971B1 (de)
JP (1) JP2821951B2 (de)
AT (1) ATE160448T1 (de)
DE (1) DE69128238T2 (de)
ES (1) ES2110998T3 (de)
FR (1) FR2665769B1 (de)
WO (1) WO1992002823A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585243A (en) * 1993-09-15 1996-12-17 The Blood Center Of Southeastern Wisconsin, Inc. Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells
US5972717A (en) * 1995-05-10 1999-10-26 The Blood Center Research Foundation, Inc. Method and kit for detecting heparin induced thrombocytopenia
FR2738916B1 (fr) * 1995-09-20 1997-11-14 Stago Diagnostica Procede d'identification precoce d'une maladie auto-immune, utilisation dans le domaine du diagnostic et necessaire de dosage pour mettre en oeuvre ce procede
JP2001504584A (ja) * 1996-11-21 2001-04-03 メルク エンド カンパニー インコーポレーテッド 拮抗薬依存性ＧＰＩＩｂ／ＩＩＩａレセプタ抗体の検出
US20060172438A1 (en) 2004-10-04 2006-08-03 David Milunic Methods and kits for detecting heparin/platelet factor 4 antibodies
JP5618831B2 (ja) * 2008-08-27 2014-11-05 株式会社Ｌｓｉメディエンス 修飾抗ヘパリン／ｐｆ４複合体抗体及びｈｉｔ抗体標準品
EP3438667B1 (de) * 2017-08-02 2020-12-30 Siemens Healthcare Diagnostics Products GmbH Bindungstest zur diagnose einer heparin-induzierten thrombozytopenie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay

Also Published As

Publication number Publication date
FR2665769A1 (fr) 1992-02-14
EP0495971A1 (de) 1992-07-29
DE69128238D1 (de) 1998-01-02
JPH05502103A (ja) 1993-04-15
FR2665769B1 (fr) 1994-04-29
JP2821951B2 (ja) 1998-11-05
ATE160448T1 (de) 1997-12-15
EP0495971B1 (de) 1997-11-19
WO1992002823A1 (fr) 1992-02-20
ES2110998T3 (es) 1998-03-01

Similar Documents

Publication Publication Date Title
Stathakis et al. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma
Fernandez et al. Chemotactic response to human C3a and C5a anaphylatoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions
ATE223044T1 (de) Nachweis von retikulozyten mit coriphosphin o
DE69329108T2 (de) Verfahren zur inaktivierung von viren
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
DE59208032D1 (de) Funktioneller Test und Reagenz zur Bestimmung von Fibrinogen
DE59109048D1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
DE69223955T2 (de) Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
DE69128238T2 (de) Nachweis von thrombopenies
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
Binette et al. The proteins of synovial fluid: A study of the α1/α2 globulin ratio
SE8004542L (sv) Diagnostiskt test
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
ES482215A1 (es) Mejoras en un metodo de radioinmunoanalisis del factor de - plaquetas y en el plasma sanguineo.
Fiedel et al. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
ES2070415T3 (es) Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
Thomas Kisker Detection of fibrin monomer: comparison of the immune precipitate method with the serial-dilution protamine sulfate test and the ethanol gel test
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
ES2066547T3 (es) Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.
SE7908794L (sv) Forfaringssett och anordning for kvantifiering av malondialdehyd
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition